Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 384

1.

Murine Prostate Micro-dissection and Surgical Castration.

Valkenburg KC, Amend SR, Pienta KJ.

J Vis Exp. 2016 May 11;(111). doi: 10.3791/53984.

PMID:
27213557
2.

A Novel Approach for Performing Bone Marrow Aspiration at the Time of Radical Prostatectomy.

Tosoian JJ, Reyes DK, Gorin MA, Hortopan S, Partin AW, Pienta KJ, Ross AE, Schaeffer EM.

Urol Case Rep. 2016 Mar 28;6:45-6. doi: 10.1016/j.eucr.2016.02.006. eCollection 2016 May.

3.

The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.

Shiozawa Y, Berry JE, Eber MR, Jung Y, Yumoto K, Cackowski FC, Yoon HJ, Parsana P, Mehra R, Wang J, McGee S, Lee E, Nagrath S, Pienta KJ, Taichman RS.

Oncotarget. 2016 May 9. doi: 10.18632/oncotarget.9251. [Epub ahead of print]

4.

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation.

Amend SR, Valkenburg KC, Pienta KJ.

J Vis Exp. 2016 Apr 14;(110). doi: 10.3791/53936.

PMID:
27168390
5.

PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges.

Rowe SP, Gorin MA, Allaf ME, Pienta KJ, Tran PT, Pomper MG, Ross AE, Cho SY.

Prostate Cancer Prostatic Dis. 2016 May 3. doi: 10.1038/pcan.2016.13. [Epub ahead of print] Review.

PMID:
27136743
6.

Stability of the hybrid epithelial/mesenchymal phenotype.

Jolly MK, Tripathi SC, Jia D, Mooney SM, Celiktas M, Hanash SM, Mani SA, Pienta KJ, Ben-Jacob E, Levine H.

Oncotarget. 2016 Mar 17. doi: 10.18632/oncotarget.8166. [Epub ahead of print]

7.

Disseminated tumor cells and dormancy in prostate cancer metastasis.

van der Toom EE, Verdone JE, Pienta KJ.

Curr Opin Biotechnol. 2016 Feb 19;40:9-15. doi: 10.1016/j.copbio.2016.02.002. [Epub ahead of print] Review.

8.

Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters.

Cheung KJ, Padmanaban V, Silvestri V, Schipper K, Cohen JD, Fairchild AN, Gorin MA, Verdone JE, Pienta KJ, Bader JS, Ewald AJ.

Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):E854-63. doi: 10.1073/pnas.1508541113. Epub 2016 Feb 1.

PMID:
26831077
9.

Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples.

Gogoi P, Sepehri S, Zhou Y, Gorin MA, Paolillo C, Capoluongo E, Gleason K, Payne A, Boniface B, Cristofanilli M, Morgan TM, Fortina P, Pienta KJ, Handique K, Wang Y.

PLoS One. 2016 Jan 25;11(1):e0147400. doi: 10.1371/journal.pone.0147400. eCollection 2016.

10.

PSMA-Based Detection of Prostate Cancer Bone Lesions With ¹⁸F-DCFPyL PET/CT: A Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT?

Rowe SP, Mana-Ay M, Javadi MS, Szabo Z, Leal JP, Pomper MG, Pienta KJ, Ross AE, Gorin MA.

Clin Genitourin Cancer. 2016 Feb;14(1):e115-8. doi: 10.1016/j.clgc.2015.09.011. Epub 2015 Sep 30. No abstract available.

PMID:
26603549
11.

Tumor Repression of VCaP Xenografts by a Pyrrole-Imidazole Polyamide.

Hargrove AE, Martinez TF, Hare AA, Kurmis AA, Phillips JW, Sud S, Pienta KJ, Dervan PB.

PLoS One. 2015 Nov 16;10(11):e0143161. doi: 10.1371/journal.pone.0143161. eCollection 2015.

12.

Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting.

Miyahira AK, Lang JM, Den RB, Garraway IP, Lotan TL, Ross AE, Stoyanova T, Cho SY, Simons JW, Pienta KJ, Soule HR.

Prostate. 2016 Feb;76(2):125-39. doi: 10.1002/pros.23107. Epub 2015 Oct 19. Review.

PMID:
26477609
13.

Bone marrow macrophages support prostate cancer growth in bone.

Soki FN, Cho SW, Kim YW, Jones JD, Park SI, Koh AJ, Entezami P, Daignault-Newton S, Pienta KJ, Roca H, McCauley LK.

Oncotarget. 2015 Nov 3;6(34):35782-96. doi: 10.18632/oncotarget.6042.

14.

Ecological paradigms to understand the dynamics of metastasis.

Amend SR, Roy S, Brown JS, Pienta KJ.

Cancer Lett. 2015 Oct 10. pii: S0304-3835(15)00622-9. doi: 10.1016/j.canlet.2015.10.005. [Epub ahead of print]

15.

Coupling the modules of EMT and stemness: A tunable 'stemness window' model.

Jolly MK, Jia D, Boareto M, Mani SA, Pienta KJ, Ben-Jacob E, Levine H.

Oncotarget. 2015 Sep 22;6(28):25161-74. doi: 10.18632/oncotarget.4629.

16.

A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902.

Rosenthal SA, Hunt D, Sartor AO, Pienta KJ, Gomella L, Grignon D, Rajan R, Kerlin KJ, Jones CU, Dobelbower M, Shipley WU, Zeitzer K, Hamstra DA, Donavanik V, Rotman M, Hartford AC, Michalski J, Seider M, Kim H, Kuban DA, Moughan J, Sandler H.

Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):294-302. doi: 10.1016/j.ijrobp.2015.05.024. Epub 2015 Jul 21.

PMID:
26209502
17.

Oligometastatic prostate cancer to the navicular bone: case report.

Reyes DK, Miller JA, Cerrato RA, Pienta KJ.

Urol Case Rep. 2015 May 1;3(3):59-62.

18.

Drug discovery in prostate cancer mouse models.

Valkenburg KC, Pienta KJ.

Expert Opin Drug Discov. 2015;10(9):1011-24. doi: 10.1517/17460441.2015.1052790. Epub 2015 Jun 1. Review.

PMID:
26027638
19.

Integrative clinical genomics of advanced prostate cancer.

Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, Beltran H, Abida W, Bradley RK, Vinson J, Cao X, Vats P, Kunju LP, Hussain M, Feng FY, Tomlins SA, Cooney KA, Smith DC, Brennan C, Siddiqui J, Mehra R, Chen Y, Rathkopf DE, Morris MJ, Solomon SB, Durack JC, Reuter VE, Gopalan A, Gao J, Loda M, Lis RT, Bowden M, Balk SP, Gaviola G, Sougnez C, Gupta M, Yu EY, Mostaghel EA, Cheng HH, Mulcahy H, True LD, Plymate SR, Dvinge H, Ferraldeschi R, Flohr P, Miranda S, Zafeiriou Z, Tunariu N, Mateo J, Perez-Lopez R, Demichelis F, Robinson BD, Schiffman M, Nanus DM, Tagawa ST, Sigaras A, Eng KW, Elemento O, Sboner A, Heath EI, Scher HI, Pienta KJ, Kantoff P, de Bono JS, Rubin MA, Nelson PS, Garraway LA, Sawyers CL, Chinnaiyan AM.

Cell. 2015 May 21;161(5):1215-28. doi: 10.1016/j.cell.2015.05.001. Erratum in: Cell. 2015 Jul 16;162(2):454.

20.

OVOL guides the epithelial-hybrid-mesenchymal transition.

Jia D, Jolly MK, Boareto M, Parsana P, Mooney SM, Pienta KJ, Levine H, Ben-Jacob E.

Oncotarget. 2015 Jun 20;6(17):15436-48.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk